<DOC>
	<DOC>NCT00670202</DOC>
	<brief_summary>To evaluate the causal relationship between Rho/Rho kinase overactivity and mechanisms of vascular dysfunction in patients with atherosclerosis.</brief_summary>
	<brief_title>Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis</brief_title>
	<detailed_description />
	<mesh_term>Carotid Stenosis</mesh_term>
	<mesh_term>Fasudil</mesh_term>
	<mesh_term>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine</mesh_term>
	<criteria>Subjects with &gt;= 70% carotid stenosis (unilateral or bilateral) who are scheduled to undergo elective carotid endarterectomy Age &gt;= 18 years Agreement of the operating surgeon for patient to participate Surgery scheduled &lt; 14 days after randomization Pregnancy ALT, GGT &gt; 3x upper limit of normal (ULN) Creatinine &gt; 3.5 mg/dL Prior intolerance to statins Reluctance to add or change dosage of statin therapy during study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Patients scheduled for elective carotid endarterectomy</keyword>
</DOC>